Friday, July 01, 2011 11:15:48 AM
CEO’s of companies will tell shareholders anything they believe they want to hear
in lieu of real results like sales, earnings, big contracts, or any real news to leak
they will resort to to mis-direction, and cliche ridden discourse called CEO speak
the lesson to be learned by this board’s posters and all readers
is we should invest our money, but not our trust in our leaders
because as is always the case; CEOs will say good things are coming soon
and regardless of reality and fact, they will promise you the moon
CEOs are not necessarily the only ones to blame for using this tool
for this is not an innate trait but something they had to learn in B-school
nevertheless, most corporate CEOs seem to take to lying like ducks to water
and as is so often the case the shareholders are blindly led to financial slaughter
the things they say are standard; although they may seem impromptu and varied
regardless of the numbers, share price, or that shareholders are getting buried
they say that there are big sales in the pipeline & profitability will be soon;
smirking, as they get in their new Benzes and rush to their tee times at noon
they may make new hires appearing to want to share the spotlight and fame
but when sales and earnings disappoint, there is now a new CFO to blame
when all fails he will swear he tried to save her, even resorting to praying to the lord
saying the economy was bad, the timing was wrong, and his hands were tied by the board
he looked so good on paper; Maxim and other companies also thought so
but before we hired Larry, should we have asked them why they let Larry go
truth is, the “E” in CEO means expendable, they come and go and are tossed aside
that's why they are so well paid, have golden parachutes, and are always grateful for the ride
Recent CYRX News
- Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024 • PR Newswire (US) • 04/30/2024 12:30:00 PM
- Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 03/12/2024 08:05:00 PM
- Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 • PR Newswire (US) • 02/27/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:42:22 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 05:22:50 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:23:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/21/2023 09:30:37 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/20/2023 05:15:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:19:00 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/15/2023 10:09:12 PM
- Form POSASR - Post-effective Amendment to an automatic shelf registration statement • Edgar (US Regulatory) • 12/15/2023 10:05:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2023 11:02:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/11/2023 10:09:00 PM
- Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services • PR Newswire (US) • 11/27/2023 01:30:00 PM
- Cryoport's CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird Express • PR Newswire (US) • 11/16/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:30:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 07:18:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:31:41 PM
- Cryoport Reports Third Quarter 2023 Financial Results • PR Newswire (US) • 11/08/2023 09:05:00 PM
- Cryoport Continues its Expansion in the European Market with Tec4med Lifescience GmbH Acquisition • PR Newswire (US) • 11/02/2023 12:30:00 PM
- Cryoport to Report Third Quarter 2023 Financial Results on November 8, 2023 • PR Newswire (US) • 10/25/2023 12:30:00 PM
- Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVF • PR Newswire (US) • 10/12/2023 12:30:00 PM
- Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies • PR Newswire (US) • 10/10/2023 12:30:00 PM
- Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies • PR Newswire (US) • 10/09/2023 08:05:00 PM
- Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award • PR Newswire (US) • 09/14/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM